Amyloid beta-protein and lipid rafts: Focused on biogenesis and catabolism

Frontiers in Bioscience - Landmark

Volumn 20, Issue 2, 2015, Pages 314-324

  Araki, Wataru ^a   Tamaoka, Akira ^b  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

ADAM10; Alzheimer's disease; Amyloid protein; BACE1; Cholesterol; Lipid rafts; Neprilysin; Review; secretase

Indexed keywords

AMYLOID BETA PROTEIN;

BIOSYNTHESIS; CELL MEMBRANE; HUMAN; METABOLISM; NERVE CELL;

AMYLOID BETA-PEPTIDES; HUMANS; MEMBRANE MICRODOMAINS; NEURONS;

EID: 84919800721     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4311     Document Type: Review

References (66)

1. J. Hardy, D.J. Selkoe: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (2002) DOI: 10.1159/000335910
2. B. De Strooper: Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol Rev 90, 465-494 (2010) DOI: 10.1152/physrev.00023.2009
3. B. De Strooper, R. Vassar, T. Golde: The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 6, 99-107 (2010) DOI: 10.1038/nrneurol.2009.218
4. C. Haass, C. Kaether, G. Thinakaran, S. Sisodia: Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2, a006270 (2012) DOI: 10.1101/cshperspect.a006270
5. S.S. Yoon, S.A. Jo: Mechanisms of amyloid-β peptide clearance: potential therapeutic targets for Alzheimer's disease. Biomol Ther (Seoul) 20, 245-255 (2012) DOI: 10.4062/biomolther.2012.20.3.245
6. L.J. Pike: Lipid rafts: bringing order to chaos. J Lipid Res 44, 655-667 (2003) DOI: 10.1194/jlr.R200021-JLR200
7. A.J. Laude, I.A. Prior: Plasma membrane microdomains: organization, function and trafficking. Mol Membr Biol 21, 193-205 (2004) DOI: 10.1080/09687680410001700517
8. K.S. Vetrivel and G. Thinakaran: Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim Biophys Acta 1801, 860-867 (2010) DOI: 10.1016/j.bbalip.2010.03.007
9. W. Araki: Beta- and gamma-secretases and lipid rafts. Opne Biol J 3, 16-20 (2010) DOI: 10.2174/1874196701003020016
10. J.V. Rushworth, N.M. Hooper: Lipid Rafts: Linking Alzheimer's amyloid-β production, aggregation, and toxicity at neuronal membranes. Int J Alzheimers Dis 2011, 603052 (2011) DOI: 10.4061/2011/603052
11. D.A. Hicks, N.N. Nalivaeva, A.J. Turner: Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling. Front Physiol 3, 189 (2012) DOI: 10.3389/fphys.2012.00189
12. L. Rajendran, W. Annaert: Membrane trafficking pathways in Alzheimer's disease. Traffic 13, 759-770 (2012) DOI: 10.1111/j.1600-0854.2012.01332.x
13. B.M. Siegenthaler, L. Rajendran: Retromers in Alzheimer's disease. Neurodegener Dis 10, 116-121 (2012) DOI: 10.1159/000335910
14. S. Brunholz, S. Sisodia, A. Lorenzo, C. Deyts, S. Kins, G. Morfini: Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells. Exp Brain Res 217, 353-364 (2012) DOI: 10.1007/s00221-011-2870-1
15. O. Lazarov, M. Lee, D.A. Peterson, S.S. Sisodia: Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 22, 9785-9793 (2002)
16. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J.C. Louis, F. Collins, J. Treanor, G. Rogers, M. Citron: Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741 (1999) DOI: 10.1126/science.286.5440.735
17. P.C. Kandalepas, R. Vassar: Identification and biology of β-secretase. J Neurochem 120 Suppl 1:55-61 (2012) DOI: 10.1111/j.1471-4159.2011.07512.x
18. K.S. Vetrivel, V. Meckler, Y. Chen, P.D. Nguyen, N.G. Seidah, R. Vassar, P.C. Wong, M. Fukata, M.Z. Kounnas, G. Thinakaran: Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts. J Biol Chem 284, 3793-3803 (2009) DOI: 10.1074/jbc.M808920200
19. K. Motoki, H. Kume, A. Oda, A. Tamaoka, A. Hosaka, F. Kametani, W. Araki: Neuronal β-amyloid generation is independent of lipid raft association of β-secretase BACE1: analysis with a palmitoylation-deficient mutant. Brain Behav 2, 270-282 (2012) DOI: 10.1002/brb3.52
20. P.Z. Chia, P.A. Gleeson: Intracellular trafficking of the β-secretase and processing of amyloid precursor protein. IUBMB Life 63, 721-729 (2011) DOI: 10.1002/iub.512
21. H. Okada, W. Zhang, C. Peterhoff, J.C. Hwang, R.A. Nixon, S.H. Ryu, T.W. Kim: Proteomic identification of sorting nexin 6 as a negative regulator of BACE1-mediated APP processing. FASEB J 24, 2783-2794 (2010) DOI: 10.1096/fj.09-146357
22. Y. Zhao, Y. Wang, J. Yang, X. Wang, Y. Zha, X. Zhang, Y.W. Zhang: Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing. Mol Neurodegener 7, 30 (2012) DOI: 10.1186/1750-1326-7-30
23. G.M. Finan, H. Okada, T.W. Kim: BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin. J Biol Chem 286, 12602-12616 (2011) DOI: 10.1074/jbc.M110.170217
24. D.R. Riddell, G. Christie, I. Hussain, C. Dingwall: Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr Biol 11: 1288-1293 (2001) DOI: 10.1016/S0960-9822(01)00394-3
25. R. Ehehalt, P. Keller, C. Haass, C. Thiele, K. Simons: Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160, 113-123 (2003) DOI: 10.1083/jcb.200207113
26. J.M. Cordy, I. Hussain, C. Dingwall, N.M. Hooper, A.J. Turner: Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci USA 100, 11735-11740 (2003) DOI: 10.1073/pnas.1635130100
27. C. Hattori, M. Asai, H. Onishi, N. Sasagawa, Y. Hashimoto, T.C. Saido, K. Maruyama, S. Mizutani, S. Ishiura: BACE1 interacts with lipid raft proteins. J Neurosci Res 84, 912-917 (2006) DOI: 10.1002/jnr.20981
28. I.S. Yoon, E. Chen, T. Busse, E. Repetto, M.K. Lakshmana, E.H. Koo, D.E. Kang: Low-density lipoprotein receptor-related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway. FASEB J 21, 2742-2752 (2007) DOI: 10.1096/fj.07-8114com
29. K.S. Vetrivel, A. Barman, Y. Chen, P.D. Nguyen, S.L. Wagner, R. Prabhakar, G. Thinakaran: Loss of cleavage at beta'-site contributes to apparent increase in beta-amyloid peptide (Abeta) secretion by beta-secretase (BACE1)-glycosylphosphatidylinositol (GPI) processing of amyloid precursor protein. J Biol Chem 286, 26166-26177 (2011) DOI: 10.1074/jbc.M111.260471
30. B. Harris, I. Pereira, E. Parkin: Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein. Brain Res 1296, 203-215 (2009) DOI: 10.1016/j.brainres.2009.07.105
31. O. Ghribi, B. Larsen, M. Schrag, M.M. Herman: High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol 200, 460-467 (2006) DOI: 10.1016/j.expneurol.2006.03.019
32. H. Xiong, D. Callaghan, A. Jones, D.G. Walker, L.F. Lue, T.G. Beach, L.I. Sue, J. Woulfe, H. Xu, D.B. Stanimirovic, W. Zhang: Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol Dis 29, 422-437 (2008) DOI: 10.1016/j.nbd.2007.10.005
33. W. Cui, Y. Sun, Z. Wang, C. Xu, L. Xu, F. Wang, Z. Chen, Y. Peng, R. Li: Activation of liver X receptor decreases BACE1 expression and activity by reducing membrane cholesterol levels. Neurochem Res 36, 1910-1921 (2011) DOI: 10.1007/s11064-011-0513-3
34. S.F. Lichtenthaler: α-secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential. J Neurochem 116, 10-21 (2011) DOI: 10.1111/j.1471-4159.2010.07081.x
35. K. Endres, F. Fahrenholz: Regulation of α-secretase ADAM10 expression and activity. Exp Brain Res 217, 343-352 (2012) DOI: 10.1007/s00221-011-2885-7
36. E. Kojro, G. Gimpl, S. Lammich, W. Marz, F. Fahrenholz: Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10. Proc Natl Acad Sci USA 98, 5815-5820 (2001) DOI: 10.1073/pnas.081612998
37. E. Kojro, P. Füger, C. Prinzen, A.M. Kanarek, D. Rat, K. Endres, F. Fahrenholz, R. Postina: Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis. J Alzheimers Dis 20, 1215-1231 (2010) DOI: 10.3233/JAD-2010-091621
38. A. Colombo, H. Wang, P.H. Kuhn, R. Page, E. Kremmer, P.J. Dempsey, H.C. Crawford, S.F. Lichtenthaler: Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines. Neurobiol Dis 49, 137-147 (2012) DOI: 10.1016/j.nbd.2012.08.011
39. M.S. Lee, S.C. Kao, C.A. Lemere, W. Xia, H.C. Tseng, Y. Zhou, R. Neve, M.K. Ahlijanian, L.H. Tsai: APP processing is regulated by cytoplasmic phosphorylation.J Cell Biol 163, 83-89 (2003) DOI: 10.1083/jcb.200301115
40. S.O. Yoon, D.J. Park, J.C. Ryu, H.G. Ozer, C. Tep, Y.J. Shin, T.H. Lim, L. Pastorino, A.J. Kunwar, J.C. Walton, A.H. Nagahara, K.P. Lu, R.J. Nelson, M.H. Tuszynski, K. Huang: JNK3 perpetuates metabolic stress induced by Abeta peptides. Neuron 75, 824-837 (2012) DOI: 10.1016/j.neuron.2012.06.024
41. B.A. Bergmans, B. De Strooper: Gamma-secretases: from cell biology to therapeutic strategies. Lancet Neurol 9, 215-326 (2010) DOI: 10.1016/S1474-4422(09)70332-1
42. S. Wahrle, P. Das, A.C. Nyborg, C. McLendon, M. Shoji, T. Kawarabayashi, L.H. Younkin, S.G. Younkin, T.E. Golde: Cholesterol-dependent gamma-secretase activity in buoyant cholesterolrich membrane microdomains. Neurobiol Dis 9, 11-23 (2002) DOI: 10.1006/nbdi.2001.0470
43. S. Wada, M. Morishima-Kawashima, Y. Qi, H. Misono, Y. Shimada, Y. Ohno-Iwashita, Y. Ihara: Gamma-secretase activity is present in rafts but is not cholesterol-dependent. Biochemistry 42, 13977-13986 (2003) DOI: 10.1021/bi034904j
44. Y. Urano, I. Hayashi, N. Isoo, P.C. Reid, Y. Shibasaki, N. Noguchi, T. Tomita, T. Iwatsubo, T. Hamakubo, T. Kodama: Association of active gamma-secretase complex with lipid rafts. J Lipid Res 46, 904-912 (2005) DOI: 10.1194/jlr.M400333-JLR200
45. K.S. Vetrivel, H. Cheng, S.H. Kim, Y. Chen, N.Y. Barnes, A.T. Parent, S.S. Sisodia, G. Thinakaran: Spatial segregation of gamma-secretase and substrates in distinct membrane domains. J Biol Chem 280, 25892-25900 (2005) DOI: 10.1074/jbc.M503570200
46. J.Y. Hur, H. Welander, H. Behbahani, M. Aoki, J.B. Fra˚nberg, Winblad, S. Frykman, L.O. Tjernberg: Active gamma-secretase is localized to detergent-resistant membranes in human brain. FEBS J 275, 1174-1187 (2008) DOI: 10.1111/j.1742-4658.2008.06278.x
47. A. Oda, A. Tamaoka, W. Araki: Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells. J Neurosci Res 88, 1137-1145 (2010) DOI: 10.1002/jnr.22271
48. H. Cheng, K.S. Vetrivel, R.C. Drisdel, X. Meckler, P. Gong, J.Y. Leem, T. Li, M. Carter, Y. Chen, P. Nguyen, T. Iwatsubo, T. Tomita, P.C. Wong, W.N. Green, M.Z. Kounnas, G. Thinakaran: S-palmitoylation of gamma-secretase subunits nicastrin and APH-1. J Biol Chem 284, 1373-1384 (2009) DOI: 10.1074/jbc.M806380200
49. P. Osenkowski, W. Ye, R. Wang, M.S. Wolfe, D.J. Selkoe: Direct and potent regulation of gamma-secretase by its lipid microenvironment. J Biol Chem 283, 22529-22540 (2008) DOI: 10.1074/jbc.M801925200
50. M.O.W. Grimm, V.C. Zimmer, J. Lehmann, H.S. Grimm, T. Hartmann: The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease. BioMed Res Int 2013, 814390 (2013) DOI: 10.1155/2013/814390
51. Z. Cai, B. Zhao, A. Ratka: Oxidative stress and β-amyloid protein in Alzheimer's disease. Neuromolecular Med 13, 223-250 (2011) DOI: 10.1007/s12017-011-8155-9
52. E. Tamagno, M. Guglielmotto, D. Monteleone, M. Tabaton: Amyloid-β production: major link between oxidative stress and BACE1. Neurotox Res 22, 208-219 (2012) DOI: 10.1007/s12640-011-9283-6
53. J.S. Miners, N. Barua, P.G. Kehoe, S. Gill, Love S: Aβ-degrading enzymes: potential for treatment of Alzheimer disease. J Neuropathol Exp Neurol 70, 944-959 (2011) DOI: 10.1097/NEN.0b013e3182345e46
54. N.N. Nalivaeva, C. Beckett, N.D. Belyaev, A.J. Turner:Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? J Neurochem 120 Suppl 1, 167-85 (2012) DOI: 10.1111/j.1471-4159.2011.07510.x
55. K. Sato, C. Tanabe, Y. Yonemura, H. Watahiki, Y. Zhao, S. Yagishita, M. Ebina, S. Suo, E. Futai, M. Murata, S. Ishiura: Localization of mature neprilysin in lipid rafts. J Neurosci Res 90, 870-877 (2012) DOI: 10.1002/jnr.22796
56. E. Hama, K. Shirotani, N. Iwata, T.C. Saido: Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neurons. J Biol Chem 279, 30259-30264 (2004) DOI: 10.1074/jbc.M401891200
57. S.M. Huang, A. Mouri, H. Kokubo, R. Nakajima, T. Suemoto, M. Higuchi, M. Staufenbiel, Y. Noda, H. Yamaguchi, T. Nabeshima, T.C. Saido, N. Iwata: Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function. J Biol Chem 281, 17941-17951 (2006) DOI: 10.1074/jbc.M601372200
58. K. Vekrellis, Z. Ye, W.Q. Qiu, D. Walsh, D. Hartley, V. Chesneau, M.R. Rosner, D.J. Selkoe: Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20, 1657-1665 (2000)
59. A. Bulloj, M.C. Leal, E.I. Surace, X. Zhang, H. Xu, M.D. Ledesma, E.M. Castaño, L. Morelli: Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Abeta and insulin degradation. Mol Neurodegener 3, 22 (2008) DOI: 10.1186/1750-1326-3-22
60. J. Pacheco-Quinto, A. Herdt, C.B. Eckman, E.A. Eckman: Endothelin-converting enzymes and related metalloproteases in Alzheimer's disease. J Alzheimers Dis 33 Suppl 1, S101-110 (2013) DOI: 10.3233/JAD-2012-129043
61. J. Pacheco-Quinto, E.A. Eckman: Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes. J Biol Chem 288, 5606-5615 (2013) DOI: 10.1074/jbc.M112.422964
62. S.O. Abdul-Hay, T. Sahara, M. McBride, D. Kang, M.A. Leissring: Identification of BACE2 as an avid β-amyloid-degrading protease. Mol Neurodegener 7, 46 (2012) DOI: 10.1186/1750-1326-7-46
63. S.T. Ferreira, W.L. Klein: The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol Learn Mem 96, 529-543 (2011) DOI: 10.1016/j.nlm.2011.08.003
64. F. Hefti, W.F. Goure, J. Jerecic, K.S. Iverson, P.A. Walicke, G.A. Krafft: The case for soluble Aβ oligomers as a drug target in Alzheimer's disease. Trends Pharmacol Sci 34, 261-266 (2013) DOI: 10.1016/j.tips.2013.03.002
65. C.L. Schengrund: Lipid rafts: keys to neurodegeneration, Brain Res Bull 82, 7-17 (2010) DOI: 10.1016/j.brainresbull.2010.02.013
66. F. Malchiodi-Albedi, V. Contrusciere, C. Raggi, K. Fecchi, G. Rainaldi, S. Paradisi, A. Matteucci, M.T. Santini, M. Sargiacomo, C. Frank, M.C. Gaudiano, M. Diociaiuti: Lipid raft disruption protects mature neurons against amyloid oligomer toxicity, Biochim Biophys Acta 1802, 406-415 (2010) DOI: 10.1016/j.bbadis.2010.01.007